Skip to main content
Caplight Logo









MedEasy

MedEasy

Private
DhakaHealthcare & Life Scienceshttps://medeasy.health/

Last Round

Seed

Sep 11, 2023

Total Funding Raised

$850,000

Momentum

Top 5%

of companies Caplight tracks

Company Overview

MedEasy is a healthcare technology company based in Bangladesh that operates an online platform for medicine delivery, doctor consultations, and diagnostic services.

Sector

Healthcare & Life Sciences

Verticals

E-commerce, Telemedicine, Patient Engagement, Pharma Supply Chain

Business Model

B2C

Customer Profile

Marketplace Commission, Usage-Based SaaS, Subscription SaaS, Payment Processing Fee

AI Layer

Non-AI

Keywords

online pharmacye-pharmacymedicine home deliverytelemedicine platformonline doctor consultationdigital healthcare platformtelehealthhome sample collectionmHealthchronic patient supporthealthcare e-commercehealthtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MedEasy Comparables

Compare MedEasy with similar companies based on industry and business-model similarity.

MedEasy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Arogga Limited
92%
DocTime
85%
Pulse Tech Ltd.
83%

MedEasy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 11, 2023
AcceleratorMay 6, 2022

Key People

Founding team and executive leadership

Nazmul Hossain

Co-Founder & CTO

Founding Team

Arefin Zaman

Co-founder & CEO

Founding Team

MedEasy Investors

Notable investors and investment history

MedEasy investors
InvestorRounds
Accelerating Asia VenturesSeed, Accelerator
SeedstarsSeed
NVenturesSeed
Doha Tech AngelsSeed
Startup Bangladesh LimitedSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 34% MoM.

  • Apr 7, 2025

    Grew 28% quarter-over-quarter, from 39 to 50 employees.

MedEasy Filings

Explore SEC and related filing metadata, where available.

MedEasy filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MedEasy's valuation, stock price, and market status.

Is MedEasy a public or private company?

MedEasy is a private company.

What is the current stock price of MedEasy?

MedEasy is a private company with no public stock price. No recent secondary market data is available.

How much is MedEasy worth (valuation)?

Valuation information for MedEasy is not publicly available.

Can I buy MedEasy stock?

MedEasy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MedEasy's last funding round?

MedEasy's most recent funding round was Seed on September 11, 2023.

Who are the main investors in MedEasy?

Key investors in MedEasy include Accelerating Asia Ventures, Seedstars.

Will MedEasy IPO soon?

No public IPO plans have been announced for MedEasy.

How can I track MedEasy secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MedEasy's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDhaka
Employee Range65
Year Founded2020
Last FundingSep 11, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?